BRCA1 and neoplasm: Additionally, not all gBRCAm tumours have dysfunctional homologous recombination (HR), for instance due to the type of BRCA1 mutation [55] or restored HR by genetic reversion of the underlying BRCA mutation [56–58], and could biologically be considered as homologous recombination proficient.